Publishing our research
We publish the key findings of our research in peer-reviewed academic journals, and our scientists participate in leading scientific conferences around the world. In line with our commitment to transparency, we always disclose funding information related to our scientific publications.
452 scientific publications from 2008 to 2021 indicate a very important scientific output since the opening of our R&D facility in 2008. We register all our clinical studies with ClinicalTrials.gov. We also collaborate with experts to verify our methods on specific scientific topics such as combustion. Read our expert reports here.
The Investigator Initiated Studies (IIS) program supports external scientists and institutions who have the relevant expertise to conduct smoke-free product research. We do this by providing financial support, product/equipment support, or technical support. The scope of the IIS program is similar to our research program, and includes aerosol chemistry, systems biology, toxicology, clinical, and post-market surveillance studies of PMI’s commercialized smoke-free products.
At PMI, we also welcome and encourage independent research on our smoke-free products and our methods and results. Sharing our science and listening to feedback are fundamental to encouraging debate with experts and the broader public.
We recognize that our scientific work must also be assessed by independent experts. We look forward to receiving independent results on our smoke-free products and to fostering open scientific conversations.
Learn more about our initiatives to encourage independent verification on smoke-free product research.